Oral NG-nitro-L-arginine in conscious dogs: 24 hour hypertensive response in relation to plasma levels

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Amino Acids

• Publication date

  1992-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00805944PMID 24192901
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• l‐NG‐nitro arginine methyl ester exhibits antinociceptive activity in the mouse

  1991cited by this paper
• Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo

  1990cited by this paper
• Control of regional blood flow by endothelium-derived nitric oxide.

  1990cited by this paper
• Regional haemodynamic changes during oral ingestion of NG‐monomethyl‐l‐arginine or NG‐nitro‐l‐arginine methyl ester in conscious Brattleboro rats

  1990cited by this paper
• Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses.

  1990cited by this paper
• l‐NG‐nitro arginine (l‐NOARG), a novel, l‐arginine‐reversible inhibitor of endothelium‐dependent vasodilatation in vitro

  1990cited by this paper
• Nitric oxide modulates epicardial coronary basal vasomotor tone in awake dogs.

  1990cited by this paper
• Regional and cardiac haemodynamic effects of NG‐nitro‐l‐arginine methyl ester in conscious, Long Evans rats

  1990cited by this paper
• NG-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo?

  1989cited by this paper
• Release of NO and EDRF from cultured bovine aortic endothelial cells.

  1989cited by this paper
• Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase.

  1989cited by this paper
• A specific inhibitor of nitric oxide formation from l‐arginine attenuates endothelium‐dependent relaxation

  1989cited by this paper
• Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein

  1989cited by this paper
• Modulation of the vasodepressor actions of acetylcholine, bradykinin, substance P and endothelin in the rat by a specific inhibitor of nitric oxide formation

  1989cited by this paper
• Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication.

  1989cited by this paper
• Role of endothelium-derived nitric oxide in the regulation of blood pressure.

  1989cited by this paper
• L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation.

  1988cited by this paper
• Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

  1987cited by this paper
• Differential selectivity of endothelium‐derived relaxing factor and nitric oxide in smooth muscle

  1987cited by this paper
• The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

  1980cited by this paper
• hypotension: Implications for the involvement of nitric oxide

  year unknowncited by this paper

• Cross-species scaling of cardiovascular safety pharmacology using PKPD modelling and simulation

  2013cites this paper
• NG‐Nitro‐L‐arginine methyl ester: a muscarinic receptor antagonist?

  1997cites this paper
• Comparative effects of N omega-nitro-L-arginine and N omega-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, bradykinin, and substance P.

  1994cites this paper
• Pharmacokinetics, plasma protein binding and urinary excretion of Nω‐nitro‐L‐arginine in rats

  1994cites this paper
• Distribution and metabolism of NG-nitro-L-arginine and NG-nitro-L-arginine methylester in canine blood in vitro

  1993cites this paper